Multiple Microbiological Tests Needed for Underweight Newborns
|
By LabMedica International staff writers Posted on 03 Mar 2013 |

Image: The oral bacteria Fusobacterium nucleatum (Photo courtesy of HealthyDent).
Cultures commonly used to detect bacterial infections in low birth-weight newborns with early onset sepsis may fail to detect some microorganisms.
There is a need for multiple detection methods, such as DNA genomic analyses and other independent culture technologies, to identify bacteria that routine culturing may miss.
Scientists at Case Western Reserve University (Cleveland, OH, USA) performed a comparative microbial analysis of paired amniotic fluid (AF) and cord blood (CB) from pregnancies complicated by preterm birth and early-onset neonatal sepsis. The biological samples from 44 women were collected from September 2004 to February 2009.
Amniotic fluid (AF) was cultured for aerobic and anaerobic bacteria, Ureaplasma and Mycoplasma species. DNA was extracted from AF or CB serum. To identify the species amplified by polymerase chain reaction (PCR) and to ensure that the PCR amplicons were indeed bacterial ribosomal ribonucleic acid (rRNA) genes rather than artifacts, the PCR products were cloned into the pCR8 vector (Invitrogen, Carlsbad, CA, USA).
The investigators found more than 20 bacterial species not discovered using standard culturing. Some of the uncultured species appeared in both the cord blood and amniotic fluid samples. The uncultured bacteria were detected with DNA genomic analysis that had been used in a prior study that discovered the link between oral bacteria that causes still- or premature-births due to infected amniotic fluid that is supposed to be a sterile environment.
Yiping Han, PhD, the professor of Periodontics and Reproductive Biology at the Case Western, said, "Culture independent technology has broadened our scope of understanding human pathogens. DNA testing techniques were able for the first time to detect the oral bacteria Fusobacterium nucleatum, Bergeyella, and Sneathia sanguinegens that brought on early neonatal sepsis and put newborns at risk of dying shortly after birth. Among these, F. nucleatum was found at the same high frequency as the well-known Escherichia coli, putting the former on the same importance scale as the latter." The study was published on February 20, 2013, in the journal Public Library of Science ONE.
Related Links:
Case Western Reserve University
Invitrogen
There is a need for multiple detection methods, such as DNA genomic analyses and other independent culture technologies, to identify bacteria that routine culturing may miss.
Scientists at Case Western Reserve University (Cleveland, OH, USA) performed a comparative microbial analysis of paired amniotic fluid (AF) and cord blood (CB) from pregnancies complicated by preterm birth and early-onset neonatal sepsis. The biological samples from 44 women were collected from September 2004 to February 2009.
Amniotic fluid (AF) was cultured for aerobic and anaerobic bacteria, Ureaplasma and Mycoplasma species. DNA was extracted from AF or CB serum. To identify the species amplified by polymerase chain reaction (PCR) and to ensure that the PCR amplicons were indeed bacterial ribosomal ribonucleic acid (rRNA) genes rather than artifacts, the PCR products were cloned into the pCR8 vector (Invitrogen, Carlsbad, CA, USA).
The investigators found more than 20 bacterial species not discovered using standard culturing. Some of the uncultured species appeared in both the cord blood and amniotic fluid samples. The uncultured bacteria were detected with DNA genomic analysis that had been used in a prior study that discovered the link between oral bacteria that causes still- or premature-births due to infected amniotic fluid that is supposed to be a sterile environment.
Yiping Han, PhD, the professor of Periodontics and Reproductive Biology at the Case Western, said, "Culture independent technology has broadened our scope of understanding human pathogens. DNA testing techniques were able for the first time to detect the oral bacteria Fusobacterium nucleatum, Bergeyella, and Sneathia sanguinegens that brought on early neonatal sepsis and put newborns at risk of dying shortly after birth. Among these, F. nucleatum was found at the same high frequency as the well-known Escherichia coli, putting the former on the same importance scale as the latter." The study was published on February 20, 2013, in the journal Public Library of Science ONE.
Related Links:
Case Western Reserve University
Invitrogen
Latest Microbiology News
- New Rapid Ebola Antigen Test Detects Infection at Point of Care
- Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
- Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
- Bacterial Growth Assay Predicts COVID-19 Severity From Plasma
- Gut Microbiome Analysis Identifies Frailty-Related Signatures in Older Adults
- CE-Marked Blood Assay Automates Tuberculosis Infection Testing
- Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants
- Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
- H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
- Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
- Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
- Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
- Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
- Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
- New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever
- TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Channels
Clinical Chemistry
view channel
Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis
Cancer cells require large amounts of nutrients to grow and proliferate, and amino acids support key processes including protein formation, energy production, and DNA synthesis. Colorectal cancer is marked... Read more
New Machine-Learning Equation Improves LDL Cholesterol Assessment
Accurate assessment of low-density lipoprotein (LDL) cholesterol is central to cardiovascular risk management, yet calculation methods can underestimate values in some patients. Laboratories widely use... Read moreMolecular Diagnostics
view channel
Point-of-Care Molecular Technology Promises Transformative Shift in Oncology
Delays in obtaining molecular test results can hinder timely oncology decisions and widen disparities for patients far from centralized laboratories. Prolonged waits may also heighten anxiety and increase... Read more
New Test Delivers Four Prenatal Genetic Screens from One Blood Sample
Prenatal genetic screening often requires multiple tests, blood draws, and follow-up appointments, delaying access to clinically relevant information. Early, consolidated insights may help clinicians coordinate... Read more
Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions
Vesicular and pustular skin lesions can stem from multiple viral pathogens, complicating timely diagnosis and management. Sequential single-pathogen testing can miss infections when the causative agent... Read more
Blood Test Guides Patient Selection for Radiopharmaceutical Therapy in Prostate Cancer
Radium-223 dichloride is a bone-targeted radiopharmaceutical therapy that improves overall survival and quality of life for many patients with metastatic castration-resistant prostate cancer (mCRPC), but... Read moreHematology
view channel
Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
imal residual disease (MRD) monitoring is pivotal in multiple myeloma, where persistent malignant plasma cells drive relapse risk and help guide therapy decisions. In the United States, approximately 202,000... Read more
New Marker Helps Detect Aggressive Multiple Myeloma Earlier
Multiple myeloma is an incurable malignancy of plasma cells and the second most common blood cancer worldwide, with more than 188,000 new cases each year. Although therapies have advanced, most patients... Read moreImmunology
view channel
Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
Sjögren’s disease is a common autoimmune condition that can be difficult to recognize early, leading to delayed diagnosis and persistent symptom burden. It affects around half a million people in the UK... Read more
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read morePathology
view channel
Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response
Breast cancer prognosis often depends on microscopic assessment of tumor architecture, a process that can be subjective and lead to variable predictions across patient groups. Quantitative measures that... Read more
AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
Myelodysplastic neoplasms, a group of blood cancers that primarily affect older adults, are challenging to stage and monitor, often requiring repeated bone marrow biopsies that can yield uncertain interpretations.... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
NanoSomiX, Inc. and Beckman Coulter Diagnostics announced a collaboration to explore the development of next-generation immunoassays for neurodegenerative diseases using extracellular vesicles (EVs).... Read more








